Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (312) 312
life sciences & biomedicine (311) 311
heart failure (261) 261
cardiovascular system & cardiology (259) 259
cardiac & cardiovascular systems (257) 257
humans (245) 245
male (158) 158
female (156) 156
aged (133) 133
middle aged (130) 130
mortality (117) 117
abridged index medicus (110) 110
cardiovascular (108) 108
hospitalization (83) 83
heart failure - physiopathology (79) 79
risk factors (74) 74
treatment outcome (71) 71
cardiac patients (68) 68
heart failure - mortality (68) 68
heart failure - drug therapy (63) 63
analysis (61) 61
clinical trials (60) 60
heart failure - therapy (58) 58
patient outcomes (55) 55
prognosis (53) 53
patients (51) 51
heart (48) 48
heart diseases (46) 46
outcomes (46) 46
medical research (44) 44
quality of life (43) 43
follow-up studies (41) 41
acute disease (39) 39
medicine, experimental (39) 39
care and treatment (38) 38
retrospective studies (38) 38
cardiovascular disease (36) 36
cardiovascular diseases (36) 36
drug therapy (36) 36
heart failure - diagnosis (36) 36
heart attacks (32) 32
stroke volume (32) 32
adult (31) 31
diabetes (31) 31
prospective studies (31) 31
studies (31) 31
united states - epidemiology (30) 30
acute heart failure (29) 29
aged, 80 and over (29) 29
comorbidity (28) 28
time factors (28) 28
disease progression (27) 27
internal medicine (27) 27
proportional hazards models (27) 27
survival rate - trends (27) 27
double-blind method (26) 26
risk assessment (26) 26
stroke volume - physiology (26) 26
cardiology (25) 25
hypertension (25) 25
heart failure - epidemiology (24) 24
exercise (23) 23
medical colleges (23) 23
research (23) 23
heart failure - complications (22) 22
peripheral vascular disease (22) 22
registries (22) 22
clinical outcomes (21) 21
kaplan-meier estimate (21) 21
hospitalization - statistics & numerical data (20) 20
diabetes mellitus (19) 19
health aspects (19) 19
hospitals (19) 19
randomized controlled trials as topic (19) 19
cause of death (18) 18
confidence intervals (18) 18
dose-response relationship, drug (18) 18
health risk assessment (18) 18
heart failure - blood (18) 18
risk (18) 18
severity of illness index (18) 18
african americans (17) 17
clinical medicine (17) 17
ejection fraction (17) 17
incidence (17) 17
type 2 diabetes (17) 17
united states (17) 17
blood pressure (16) 16
body mass index (16) 16
epidemiology (16) 16
biological and medical sciences (15) 15
clinical trials as topic (15) 15
diuretics (15) 15
heart failure - ethnology (15) 15
medical sciences (15) 15
regression analysis (15) 15
stroke (15) 15
cardiology and cardiovascular medicine (14) 14
congestion (14) 14
variables (14) 14
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (566) 566
French (5) 5
German (5) 5
Portuguese (2) 2
Spanish (2) 2
Danish (1) 1
Japanese (1) 1
Norwegian (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Adding Troponin to the Puzzle of Heart Failure With Preserved Ejection Fraction: Marker or Mediator?
by Mentz, Robert J and Greene, Stephen J
Journal of the American College of Cardiology, ISSN 0735-1097, 07/2018, Volume 72, Issue 1, pp. 41 - 44
heart failure | HFpEF | troponin | biomarker | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Stroke Volume | Biomarkers | Heart Failure | Troponin | Natriuretic Peptide, Brain | Humans | Heart failure | Exercise | Ischemia | Calcium-binding protein | Medical prognosis | Clinical trials | Cardiovascular disease | Heart diseases | Clinical outcomes | Ejection fraction
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Relation of Early Repolarization (J Point Elevation) to Mortality in Blacks (from the Jackson Heart Study)
by Kelly, Jacob P and Greiner, Melissa and Soliman, Elsayed Z and Randolph, Tiffany C and Thomas, Kevin L and Dunlay, Shannon M and Curtis, Lesley H and O'Brien, Emily C and Mentz, Robert J
The American journal of cardiology, ISSN 0002-9149, 07/2018, Volume 122, Issue 2, pp. 340 - 346
Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Heart failure | Hypertension | EKG | Mortality | Hazards | Hospitalization | Incidence | Confidence intervals | Studies | Surveillance | Electrocardiography | Population | Heart diseases
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
by Holman, Rury R and Bethel, M. Angelyn and Mentz, Robert J and Thompson, Vivian P and Lokhnygina, Yuliya and Buse, John B and Chan, Juliana C and Choi, Jasmine and Gustavson, Stephanie M and Iqbal, Nayyar and Maggioni, Aldo P and Marso, Steven P and Öhman, Peter and Pagidipati, Neha J and Poulter, Neil and Ramachandran, Ambady and Zinman, Bernard and Hernandez, Adrian F and EXSCEL Study Grp and EXSCEL Study Group
The New England journal of medicine, ISSN 0028-4793, 09/2017, Volume 377, Issue 13, pp. 1228 - 1239
no | Medicine(all) | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Exenatide | Peptides - administration & dosage | Incidence | Cardiovascular Diseases - complications | Hypoglycemic Agents - administration & dosage | Injections, Subcutaneous | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Venoms - administration & dosage | Female | Diabetes Mellitus, Type 2 - complications | Double-Blind Method | Drug Administration Schedule | Venoms - adverse effects | Kaplan-Meier Estimate | Diabetes Mellitus, Type 2 - blood | Least-Squares Analysis | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Peptides - adverse effects | Type 2 diabetes | Usage | Patient outcomes | Outcome and process assessment (Health Care) | Reports | Dosage and administration | Drug therapy | Observations | Myocardial infarction | Cerebral infarction | Diabetes mellitus | Pancreatitis | Amylin | Cardiovascular disease | Patients | Thyroid carcinoma | Studies | Side effects | Pancreatic carcinoma | Pancreatic cancer | Diabetes | Health risk assessment | Heart diseases | Endocrinology | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Erratum to ‘The role of angiotensin receptor–neprilysin inhibitors in cardiovascular disease—existing evidence, knowledge gaps, and future directions' [Eur J Heart Fail 2018;20:963–972]
by Ambrosy, Andrew P and Mentz, Robert J and Fiuzat, Mona and Cleland, John G.F and Greene, Stephen J and O'Connor, Christopher M and Teerlink, John R and Zannad, Faiez and Solomon, Scott D
European journal of heart failure, ISSN 1388-9842, 06/2019, Volume 21, Issue 6, pp. 819 - 819
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Clinical characteristics, response to exercise training, and outcomes in patients with heart failure and chronic obstructive pulmonary disease: Findings from Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION)
by Mentz, Robert J., MD and Schulte, Phillip J., PhD and Fleg, Jerome L., MD and Fiuzat, Mona, PharmD and Kraus, William E., MD and Piña, Ileana L., MD, MPH and Keteyian, Steven J., MD and Kitzman, Dalane W., MD and Whellan, David J., MD, MHS and Ellis, Stephen J., PhD and O'Connor, Christopher M., MD
The American heart journal, ISSN 0002-8703, 2013, Volume 165, Issue 2, pp. 193 - 199
Cardiovascular | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Exercise Therapy - methods | Heart Failure - rehabilitation | Pulmonary Disease, Chronic Obstructive - mortality | United States - epidemiology | Prospective Studies | Follow-Up Studies | Comorbidity | Humans | Middle Aged | Heart Failure - physiopathology | Proportional Hazards Models | Male | Survival Rate | Treatment Outcome | Pulmonary Disease, Chronic Obstructive - physiopathology | Stroke Volume | Pulmonary Disease, Chronic Obstructive - rehabilitation | Female | Aged | Exercise - physiology | Heart Failure - mortality | Heart failure | Medical research | Lung diseases, Obstructive | Exercise | Patient outcomes | Cardiac patients | Medicine, Experimental | Chronic obstructive pulmonary disease | Heart attacks | Drug therapy | Patients | Mortality | Older people | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Efficacy and Safety of Tolvaptan in Patients Hospitalized with Acute Heart Failure
by Felker, G. Michael, MD, MHS, FACC and Mentz, Robert J., MD and Cole, Robert, MD and Adams, Kirkwood F., MD and Egnaczyk, Gregory F., MD and Fiuzat, Mona, PharmD and Patel, Chetan B., MD and Echols, Melvin, MD and Khouri, Michel G., MD and Tauras, James M., MD and Gupta, Divya, MD and Monds, Pamela, MBA and Roberts, Rhonda, MPH and O’Connor, Christopher M., MD, FACC
Journal of the American College of Cardiology, ISSN 0735-1097, 2016, Volume 69, Issue 11, pp. 1399 - 1406
Cardiovascular | Internal Medicine | volume overload | decongestion | acute heart failure | outcomes | strategies | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Prospective Studies | Double-Blind Method | Humans | Middle Aged | Male | Antidiuretic Hormone Receptor Antagonists - therapeutic use | Heart Failure - drug therapy | Kidney Function Tests | Tolvaptan | Benzazepines - therapeutic use | Dyspnea - drug therapy | Female | Aged | Heart failure | Heart | Medicine, Experimental | Medical colleges | Medical research | Cardiac patients | Furosemide | Therapy | Tactics | Edema | Renal function | Peptides | Mortality | Weight loss | Congestion | FDA approval | Congestive heart failure | Patients | Vasopressin | Clinical outcomes | Randomization | Dyspnea | Diuretics | Respiration | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial
by Szarek, Michael and White, Harvey D and Schwartz, Gregory G and Alings, Marco and Bhatt, Deepak L and Bittner, Vera A and Chiang, Chern-En and Diaz, Rafael and Edelberg, Jay M and Goodman, Shaun G and Hanotin, Corinne and Harrington, Robert A and Jukema, J. Wouter and Kimura, Takeshi and Kiss, Robert Gabor and Lecorps, Guillaume and Mahaffey, Kenneth W and Moryusef, Angèle and Pordy, Robert and Roe, Matthew T and Tricoci, Pierluigi and Xavier, Denis and Zeiher, Andreas M and Steg, Ph. Gabriel and ODYSSEY OUTCOMES Comm Investigator and ODYSSEY OUTCOMES Committees and Investigators
Journal of the American College of Cardiology, ISSN 0735-1097, 02/2019, Volume 73, Issue 4, pp. 387 - 396
alirocumab | total events | acute coronary syndrome | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Acute Coronary Syndrome - drug therapy | Antibodies, Monoclonal, Humanized | Follow-Up Studies | Humans | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Middle Aged | Antibodies, Monoclonal - therapeutic use | Female | Male | Aged | Drug Therapy, Combination | Myocardial infarction | Heart | Heart attacks | Risk | Cardiovascular disease | Family medical history | Angina | Confidence intervals | Heterogeneity | Ischemia | Frailty | Heart diseases | Statins | Cerebral infarction | Stroke | Mortality | Hospitalization | Angina pectoris | Estimates | Patients | Health hazards | Death | Fatalities | Infarction | Diabetes | Acute coronary syndromes | Health risk assessment
Journal Article
Details down arrow
8. Full Text Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial)
by Mentz, Robert J., MD and Hasselblad, Vic, PhD and DeVore, Adam D., MD and Metra, Marco, MD and Voors, Adriaan A., MD and Armstrong, Paul W., MD and Ezekowitz, Justin A., MBBCh and Tang, W.H. Wilson, MD and Schulte, Phillip J., PhD and Anstrom, Kevin J., PhD and Hernandez, Adrian F., MD, MHS and Velazquez, Eric J., MD and O'Connor, Christopher M., MD
The American journal of cardiology, ISSN 0002-9149, 02/2016, Volume 117, Issue 3, pp. 404 - 411
Cardiovascular | UNITED-STATES | MANAGEMENT | THERAPY | MYOCARDIAL FIBROSIS | TORASEMIDE | QUALITY-OF-LIFE | OUTCOMES | DIURETIC TREATMENT | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Furosemide - administration & dosage | Acute Disease | Survival Rate - trends | Double-Blind Method | Follow-Up Studies | Global Health | Humans | Middle Aged | Heart Failure - physiopathology | Stroke Volume - drug effects | Male | Treatment Outcome | Heart Failure - drug therapy | Dose-Response Relationship, Drug | Hospitalization - trends | Cause of Death - trends | Female | Aged | Retrospective Studies | Sodium Potassium Chloride Symporter Inhibitors - administration & dosage | Sulfonamides - administration & dosage | Heart Failure - mortality | Heart failure | Care and treatment | Analysis | Mortality | Cardiac patients | Furosemide | Natriuretic peptides | Confidence intervals | Variables | Heart attacks | Laboratories | Diuretics | Nitrogen | Patients | Logistics | Index Medicus | Abridged Index Medicus | furosemide | heart failure | torsemide | loop diuretics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome ODYSSEY OUTCOMES Trial
by Jukema, J. Wouter and Zijlstra, Laurien E and Bittner, Vera A and Goodman, Shaun G and Karpov, Yuri and Tricoci, Pierluigi and Moryusef, Angele and Sasiela, William J and Tamby, Jean-Francois and Drexel, Heinz and Gotcheva, Nina N and Nieminen, Markku S and Xavier, Denis and Kim, Hyo Soo and Kim, Sang-Hyun and Kedev, Sasko and Laucevicius, Aleksandras and Dalby, Anthony J and Tunon, Jose and Chiang, Chern-En and Parkhomenko, Alexander and Moriarty, Patrick M and Rosenson, Robert and Sijbrands, Eric J. G and Dombrowski, Keith and Ducrocq, Gregory and Eppinger, Arleen and Hlatky, Mark A and Jordan, Joseph Dedrick and Leonardi, Sergio and Maron, David J and Moreira, Humberto Graner and Stringfellow, Kenya and Yan, Andrew Tze-Kay and Trotter, Charlene and Schmidberg, Jorge M and Angel Hominal, Miguel and Montana, Oscar R and Caime, Guillermo D and Salomone, Rodolfo and Bono, Julio O. E and Carnero, Gabriela S and Guzman, Pablo N and Liberman, Alberto and Saavedra, Silvia S and Zapata, Gerardo and Soward, Allan and Shaw, James and Arstall, Margaret A and Rogers, James F and Colquhoun, David and Coverdale, Steven G. M and Garrahy, Paul J and Starmer, Gregory and Sader, Mark and Zweiker, Robert and Hermans, Kurt and Vrolix, Mathias C. M and Wollaert, Bart and Dujardin, Karl and Striekwold, Harry and Roosen, John and Cools, Frank and Midzic, Zlatko and Fazlibegovic, Emir and Muslibegovic, Adis and Goronja, Boris and Sousa, Luciano and Silva, Ricardo P and Maia, Lilia Nigro and Duda, Norberto and Pimentel Filho, Pedro and Soggia, Ana Priscila and Neuenschwander, Fernando and Moura Jorge, Jose C and Saporito, Wladmir and Feitosa, Gilson S and de Souza, Juliana A and Machado, Leandro and Benov, Haralambi O and Petranov, Stanislav L and Markov, Dimitar T and Mollov, Mihail N and Stone, James and Kornder, Jan and Savard, Daniel and Hoag, Gordon and Morisset, Anne and Sussex, Bruce and Kouz, Simon and MacDonald, Paul and Michaud, Nicolas and Leung, Raymond and Lai, Christopher and Vijayaraghavan, Ram and Ducas, John and Lepage, Serge and Vejar, Margarita and Perez, Luis and Florenzano, Fernando and ... and ODYSSEY OUTCOMES Comm Investigator and ODYSSEY OUTCOMES Committees and Investigators
Journal of the American College of Cardiology, ISSN 0735-1097, 09/2019, Volume 74, Issue 9, pp. 1167 - 1176
Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiovascular Diseases - etiology | Dyslipidemias - drug therapy | Vascular Diseases - prevention & control | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Dyslipidemias - complications | Risk Assessment | Vascular Diseases - etiology | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Treatment Outcome | Vascular Diseases - epidemiology | Acute Coronary Syndrome - complications | Cardiovascular Diseases - epidemiology | Female | Aged | Myocardial infarction | Therapy | Heart attacks | Dyslipidemia | Cardiovascular disease | Lipids | Angina | Incidence | Confidence intervals | Reduction | Ischemia | Atherosclerosis | Cardiology | Heart diseases | Statins | Cerebral infarction | Evaluation | Stroke | Medical treatment | Mortality | Health risks | Risk reduction | Subtilisin | Angina pectoris | Coronary artery disease | Kexin | Arteriosclerosis | Coronary vessels | Death | Diabetes | Acute coronary syndromes | Risk management | Cardiovascular diseases | Health risk assessment
Journal Article
Details down arrow
10. Full Text Reduction of Cardiovascular Risk and Improved Estimated Glomerular Filtration Rate by SGLT2 Inhibitors, Including Dapagliflozin, Is Consistent Across the Class: An Analysis of the Placebo Arm of EXSCEL
by Clegg, Lindsay E and Heerspink, Hiddo J L and Penland, Robert C and Tang, Weifeng and Boulton, David W and Bachina, Srinivas and Fox, Robert D and Fenici, Peter and Thuresson, Marcus and Mentz, Robert J and Hernandez, Aian F and Holman, Rury R
Diabetes care, ISSN 0149-5992, 02/2019, Volume 42, Issue 2, pp. 318 - 326
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Control | Dosage and administration | Cardiovascular diseases | Dapagliflozin | Risk factors | Glomerular filtration rate | Inhibitors | Epidermal growth factor receptors | Sodium | Health risks | Risk | Research design | Mathematical models | Regression analysis | Health risk assessment
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Improving cardiovascular clinical trials conduct in the United States: Recommendation from clinicians, researchers, sponsors, and regulators
by Butler, Javed, MD, MPH and Fonarow, Gregg C., MD and O’Connor, Christopher, MD and Adams, Kirkwood, MD and Bonow, Robert O., MD, MS and Cody, Robert J., MD, MBA and Collins, Sean P., MD, MSc and Dunnmon, Preston, MD, MBA and Dinh, Wilfried, MD and Fiuzat, Mona, PharmD and Georgiopoulou, Vasiliki V., MD, MPH and Grant, Stephen, MD and Kim, So-Young, MD and Kupfer, Stuart, MD and Lefkowitz, Martin, MD and Mentz, Robert J., MD and Misselwitz, Frank, MD, PhD and Pitt, Bertram, MD and Roessig, Lothar, MD and Schelbert, Erik, MD, MS and Shah, Monica, MD and Solomon, Scott, MD and Stockbridge, Norman, MD and Yancy, Clyde, MD, MS and Gheorghiade, Mihai, MD
The American heart journal, ISSN 0002-8703, 2014, Volume 169, Issue 3, pp. 305 - 314
Cardiovascular | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Personnel Selection | Clinical Trials as Topic - economics | United States | Humans | Heart Failure | Clinical Trials as Topic - standards | Practice Guidelines as Topic | Medicine, Experimental | Clinical trials | Medical research | Therapeutics | Homeopathy | Materia medica and therapeutics | Heart failure | Costs | Biomedical research | Disease | Meetings | Laboratories | Infrastructure | Trends | Pharmaceutical industry | Drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights